MESOTHELIOMA, MALIGNANT
Clinical trials for MESOTHELIOMA, MALIGNANT explained in plain language.
Never miss a new study
Get alerted when new MESOTHELIOMA, MALIGNANT trials appear
Sign up with your email to follow new studies for MESOTHELIOMA, MALIGNANT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Immunotherapy duo shows promise against rare lung cancer in chinese trial
Disease control CompletedThis study tested whether a combination of two immunotherapy drugs (nivolumab and ipilimumab) works better than standard chemotherapy for Chinese patients with advanced pleural mesothelioma, a rare cancer of the lung lining. 102 patients who could not have surgery were randomly a…
Matched conditions: MESOTHELIOMA, MALIGNANT
Phase: PHASE2 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New combo therapy shows promise for rare lung cancer
Disease control CompletedThis phase 2 trial tested whether adding low-dose chemotherapy to radiation before surgery, followed by immunotherapy after surgery, could help people with malignant mesothelioma. Thirty participants were enrolled. The goal was to see if this approach boosts the immune system's a…
Matched conditions: MESOTHELIOMA, MALIGNANT
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC